1. Dr. Ken K. Nischal Breaks Down the WSPOS 2025 Consensus Statement
The WSPOS 2025 Myopia Consensus Statement brings clarity to one of the most complex topics in pediatric eye care. In this episode of the WSPOS IME expert video series Dr. Ken K. Nischal distills the data into clear, evidence-based strategies for managing myopia progression.
The statement clarifies which interventions actually work, like defocus optical designs, low-dose atropine and daily outdoor light exposure, and debunks those that don’t, including undercorrection and bifocals.
Dr. Nischal also emphasizes practical behavioral strategies: spend 2 hours outdoors daily, avoid reading in dim light and take regular near-work breaks. Together, these steps form the foundation for real-world myopia control that’s guided by science, not speculation.
Read the full consensus at https://wspos.org/myopia/
Independent medical education supported by Essilor (Gold), Santen (Gold), Hoya (Silver), Cooper Vision (Silver), Eye Rising (Bronze).
2. Prof. Mark Bullimore on Evidence-Based Strategies for Myopia Control | WSPOS 2025
In myopia management, it’s not just what you prescribe…it’s what the child will actually use.
In this episode of the WSPOS IME expert video series, Prof. Mark Bullimore breaks down the latest evidence on myopia control treatments, from HAL lenses and orthokeratology to atropine and soft contact lenses. He shares how real-world efficacy depends on adherence, availability and expectation setting.
Hear how he simplifies a crowded treatment landscape into practical, evidence-based strategies that clinicians can apply right away.
3. Prof. Annegret Dahlmann-Noor on Access and Awareness Across Europe | WSPOS 2025
In Episode 3 of the WSPOS IME expert video series, Prof. Annegret Dahlmann-Noor (Moorfields Eye Hospital, UK) explores how the WSPOS 2025 Myopia Consensus Statement can guide care across Europe’s diverse healthcare systems.
She highlights practical realities for clinicians, from atropine access and formulation challenges to lifestyle factors like outdoor time, and emphasizes that awareness and education remain as vital as treatment itself.
For more, visit https://forum.wspos.org
Independent medical education supported by Essilor (Gold), Santen (Gold), Hoya (Silver), Cooper Vision (Silver), Eye Rising (Bronze).
4. Dr. Seo Wei Leo on Customizing Myopia Care for Asian Children
In Asia, myopia control isn’t just a clinical issue, it’s a public health priority.
In this episode of the WSPOS IME expert video series, Dr. Seo Wei Leo shares how she tailors treatment for each child by balancing environmental, genetic and lifestyle factors. From low-dose atropine and optical interventions to combination therapy and outdoor time, she highlights a truly customized approach for Asia’s unique challenges.
Discover how evidence-based care, compliance and family education come together to slow myopia progression across one of the world’s most affected regions.
For more, visit https://forum.wspos.org
Independent medical education supported by Essilor (Gold), Santen (Gold), Hoya (Silver), Cooper Vision (Silver), Eye Rising (Bronze).
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
